Hepatocellular carcinoma (HCC) is ranked as the sixth most common cancer worldwide and its incidence has been progressively increasing. HCC is also the third most common cause of cancer-related death, with a 5-year survival rate of just 3% 1 . Inter...

Treatment on Antibiotic Resistance in Helicobacter Pylori Helicobacter pylori (H. pylori) is a bacterium that infects more than half of the worldwide population. H. pylori infection is the main cause of chronic gastritis and the etiological agent fo...

Current Handling of HCV Treatment With the current approach of hepatitis C virus (HCV) treatment, Hong Kong has aligned itself with the World Health Organization (WHO) strategy to eliminate viral hepatitis as a major public health threat by 2030 1 ....

Pharmacological Advantages of TAF over TDF Both TDF and TAF are recommended as the first-line therapy for CHB management 5 . However, TAF is more stable than TDF in plasma and delivers the active metabolite to hepatocytes more efficiently, allowing ...